In particular, MMP-2 and IL-6 for offspring exposed to the control diet, and the synthesis/atrophy pathways, PPAR-α, and NFκ-B/cytokine axis for offspring submitted to HFD are relevant candidates modulated by paternal RT that may become potential therapeutic targets for treating skeletal muscle disorders. This evidence concerns the gene NFKB1 and skeletal muscle disorder.